Oneinforty, a non-profit organization providing education and support to those at risk of hereditary cancer, is launching a new webinar series entitled, “Living with Hereditary Cancer During COVID-19”. Dr. Judy Garber, Director of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute, kicks off the series on Thursday, April 30th at 3 p.m. EST. This event is free to attend. Register at oneinforty.org
BOSTON (PRWEB) APRIL 28, 2020
Oneinforty, a non-profit organization providing education and support to those at risk of hereditary cancer, is launching a new webinar series entitled, “Living with Hereditary Cancer During COVID-19”. Dr. Judy Garber, Director of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute, kicks off the series on Thursday, April 30th at 3 p.m. EST.
In these uncertain times, individuals with hereditary cancer or a gene mutation making them at increased risk of cancer, face unique challenges. Many are struggling to get access to a genetic counselor. Many are currently in treatment and worried about going into a hospital. Many are participating in clinical trials that may be paused. Many are experiencing mental distress.
To continue supporting our community, Oneinforty’s new webinar series will feature experts in oncology, genetics, and mental health. The series will feature guest speakers from Dana-Farber Cancer Institute, Massachusetts General Hospital and the Virginia Thurston Healing Garden among other organizations.
All webinars in the series are free of charge and open to the general public. The expert speakers will discuss the impact of COVID-19 on those living with hereditary cancers and their families and caregivers, updates on genetic testing and screening, support for caregivers and their families, and taking care of your mental health.
Registration is now open for all events, please register online at our website. http://oneinforty.org/upcoming-events/.
The first two events in our series:
Thursday, April 30, 2020 at 3 p.m. EST
COVID-19 and Living With Hereditary Cancer: What You Need To Know
Dr. Judy Garber, Director of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute
May 12, 2020, 6:30 pm EST
Covid-19 and Hereditary Cancer: Updates on Genetic Testing and Screening
Jill E. Stopfer, MS, LGC, Associate Director, Genetic Counseling, Cancer Center Genetics and Prevention, Dana-Farber Cancer Institute
How You Can Help From Home
As the Coronavirus continues to impact the community, we want to extend our heartfelt wishes during these times. Our thoughts especially go out to those who have been directly impacted by the virus, and our gratitude goes out to the healthcare professionals who are on the front lines of this global pandemic.
We at Oneinforty, are committed to continue supporting our community with our public health efforts. Please consider making a donation to help us continue our critical work.
About Oneinforty
Founded in 2017 by Lauren Corduck, a BRCA-positive ovarian cancer thriver, Oneinforty is a nonprofit organization that raises awareness of the one-in-forty risk to Ashkenazi Jews of inheriting cancer-causing BRCA gene mutations and provides the support individuals and families need to effectively manage their cancer risk. Learn more at http://www.oneinforty.org. Follow us on Facebook and LinkedIn.
Oneinforty
To support our community, Oneinforty’s new webinar series will feature experts in oncology, genetics, and mental health. The series will feature guest speakers from Dana-Farber Cancer Institute, Massachusetts General Hospital and the Virginia Thurston Healing Garden among other organizations.
